Intelligence · Clinical Development
Pipeline search results
Programs matching “cemiplimab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 52 pipeline programs matching "cemiplimab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Cemiplimab
Regeneron UK Limited
Cutaneous Squamous Cell Carcinoma
7 trials -
Cemiplimab
Regeneron UK Limited
Cutaneous Squamous Cell Carcinoma (CSCC)
1 trial -
Cemiplimab
Regeneron UK Limited
Recurrent Lung Non-Small Cell Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
Squamous Cell Carcinoma (SCC)
1 trial -
Placebo, CEMIPLIMAB
Ningbo Cancer Hospital
Non-small cell lung cancer
1 trial -
cemiplimab
Regeneron UK Limited
Non-small Cell Lung Cancer
3 trials -
Alirocumab and Cemiplimab
Regeneron UK Limited
Non-small Cell Lung Cancer (NSCLC)
1 trial -
CEMIPLIMAB
Fondazione Telethon ETS
surgically resectable, high risk stage III/IV (M0) Cutaneaous Squamous Cell Carcinoma, Cutaneaous Squamous Cell Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
High-Grade Glioma (HGG)
1 trial -
Cemiplimab
Regeneron UK Limited
Colon and Rectal Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Hepatitis B Virus
1 trial -
Cemiplimab
Regeneron UK Limited
Head and Neck Squamous Cell Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
Hodgkin Lymphoma
1 trial -
Cemiplimab
Regeneron UK Limited
Basal Cell Carcinoma (BCC)
1 trial -
Cemiplimab
Regeneron UK Limited
Cervical Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Colo-rectal Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Colon Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Metastatic Solid Tumor
1 trial -
Cemiplimab
Regeneron UK Limited
Colorectal Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Carcinoma, Non-Small-Cell Lung
1 trial -
Cemiplimab
Regeneron UK Limited
HIV Infections
1 trial -
Cemiplimab
Regeneron UK Limited
Bladder Urothelial Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
HPV-Related Squamous Cell Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
Locally Advanced Basal Cell Carcinoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.